跳至主要内容
临床试验/CTRI/2012/03/002478
CTRI/2012/03/002478招募中4 期

Evaluation of the effect of combination of moxifloxacin and voriconazole on QT interval of healthy volunteer and renal failure patients

Postgraduate Institute of Medical Education and Research0 个研究点目标入组 16 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Healthy volunteers who gives consent to participate in the study
  • Renal failure patients whose creatinine clearance is 10-50 ml/min

排除标准

  • Baseline QTC interval >450millisec on 3 repeated occasions
  • Use of concomitant medication that prolong QT interval
  • Use of any drug that inhibit or induce CYP450 enzymes and/or P-gp within 30 days prior to screening
  • family history of congenital long QT syndrome (LQTS) or sudden death
  • known allergic or contraindication to voriconazole or moxifloxacin
  • Pregnant or lactating mother
  • HIV positive patient
  • HBsAg positive individuals
  • Alcoholics and
  • Presence of significant cardiovascular, pulmonary, hepatic, renal, haematological, gastrointestinal, endocrine, immunologic, dermatologic, neurological, or psychiatric disease

研究者

相似试验